Literature DB >> 21163634

Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

Sheng-Hsiang Lin, Chih-Cheng Lai, Che-Kim Tan, Wan-Hsiu Liao, Po-Ren Hsueh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21163634     DOI： 10.1016/j.ijantimicag.2010.10.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.

Authors:  Takafumi Nakano; Yoshihiko Nakamura; Tohru Takata; Keiichi Irie; Kazunori Sano; Osamu Imakyure; Kenichi Mishima; Koujiro Futagami
Journal:  Int J Clin Pharm       Date:  2016-04-28

Review 2.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Young Kyung Yoon; Dae Won Park; Jang Wook Sohn; Hyo Youl Kim; Yeon-Sook Kim; Chang-Seop Lee; Mi Suk Lee; Seong-Yeol Ryu; Hee-Chang Jang; Young Ju Choi; Cheol-In Kang; Hee Jung Choi; Seung Soon Lee; Shin Woo Kim; Sang Il Kim; Eu Suk Kim; Jeong Yeon Kim; Kyung Sook Yang; Kyong Ran Peck; Min Ja Kim
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

4.  Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis.

Authors:  Shinichi Watanabe; Yukinobu Kawakami; Hiroshi Kimura; Shinobu Murakami; Hitoshi Miyamoto; Shingo Takatori; Koichiro Suemori; Mamoru Tanaka; Akihiro Tanaka; Keiko Tanaka; Hisamichi Tauchi; Jun Maki; Hiroaki Araki; Takumi Yamaguchi
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

5.  Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections.

Authors:  Lijuan Zhou; Long Cheng; Yanqiu Gao; Wei Cao; Jia Liu; Hongya Guan; Hua Zhang; Yun Shi; Wenying Lv
Journal:  Infect Drug Resist       Date:  2018-01-05       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.